Overview
Leading international law firm McDermott Will & Emery is hosting its first Hospital & Health Systems Innovation Summit on Thursday, October 24, 2019, at the Lotte New York Palace.
The Innovation Summit will facilitate discussions among hospital and health system innovation leaders, including c-suite executives, in-house counsel and other healthcare leaders regarding business, regulatory, compliance and legal challenges they face when navigating innovation efforts within their system.
“Hospitals and health systems are spurring innovation efforts to accelerate improvement to patient care and services. This forum will give hospital and health system leaders the insights needed to anticipate and address business, transactional and regulatory issues in connection with these novel arrangements and investments,” said Kerrin Slattery, co-chair of the summit and a Chicago-based partner.
“Although hospitals and health systems and academic medical centers have been pivotal participants in research and development for years, the landscaping is now shifting. Health systems and medical centers are forming venture funds to facilitate investments and getting directly involved with startup companies to not only license out technology for outside development but to remain intimately involved in the full life cycle of product and service development,” said Kristian Werling, co-chair of the summit and co-chair of the Firm’s Life Sciences Practice, based in Chicago.
“These types of investments require a new skill-set and an understanding of how these investments can play out, both for good and for bad,” Kristian said.
Panel topics will include:
- A look at the evolution of innovation centers, including the opportunities, challenges and strategies related to innovation center development, infrastructure and investments
- Approaches for developing successful investment structures, including an understanding of venture-style investments and startups
- What you need to know about data collaborations, including the legal and regulatory issues unique to patient, clinical and third party data
- Diligence strategies at every stage of a company’s life cycle, and strategies for risk assessment and deal terms
- Key governance best practices and planning considerations for the board
Lessons learned from innovation investment arrangements, including preparing for the unexpected, and exit strategies Additional McDermott lawyers hosting the event will be Stephen Bernstein, co-chair of the Firm’s Life Sciences Practice and co-leader of the Firm’s Digital Health affinity group, and Michael Peregrine, who is a regular Forbes.com contributor on governance concerns.
Members of the media who are interested in talking to attendees in advance of this event should contact Stephen Hastings at shastings@mwe.com or +1-202-756-8052 or Rebecca Shore at rshore@mwe.com or +1-202-756-8987.
McDermott Will & Emery is the nation’s leading healthcare law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as “Health Team of the Year” in 2010, 2013, 2017 and 2019. McDermott has held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity since 2017.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 20 locations on three continents, our team works seamlessly across practices, industries and geographies to deliver highly effective—and often unexpected—solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
